Sphingomyelin and ceramide as regulators of development and lifespan

Mechanisms of Ageing and Development

Volumn 122, Issue 9, 2001, Pages 895-908

  Cutler, Roy G ^a   Mattson, Mark P ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Antioxidant; Cancer; Cardiovascular disease; Evolution; Oxidative stress; Sphingolipids; Tumor necrosis factor

Indexed keywords

CERAMIDE; GROWTH FACTOR; HORMONE; INTERLEUKIN 1BETA; NEUROTRANSMITTER; PHOSPHATASE; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AGING; APOPTOSIS; ATHEROSCLEROSIS; BREAST CARCINOMA; CALORIC RESTRICTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DEGENERATIVE DISEASE; LIFESPAN; LIPID METABOLISM; MALE TYPE ALOPECIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CERAMIDES; DISEASE; HUMANS; LONGEVITY; SPHINGOMYELINS;

ANIMALIA;

EID: 0035880016     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(01)00246-9     Document Type: Review

References (79)

1. Adams-Klages, S., Adams, D., Wiegmann, K., Struve, S., Kolanus, W., SchneiderMergener, J., Kronke, M., 1996. FAN, a novel WD-repeat protein, couples the p55 TNF receptor to neutral sphingomyelinase. Cell 86, 937-947.
2. Adam-Klages, S., Schwandner, R., Adam, D., Kreder, D., Bernardo, K., Kronke, M., 1998. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J. Leukoc. Biol. 63, 678-682.
3. Ballou, L.R., Laulederkind, S.J., Rosloniec, E.F., Raghow, R., 1996. Ceramide signalling and the immune response. Biochim. Biophys. Acta 1301, 273-287.
4. Bjorntorp, P., 1995. Neuroendocrine ageing. J. Intern. Med. 238, 401-404.
5. Brawley, O.W., Pames, H., 2000. Prostate cancer prevention trials in the USA. Fur. J. Cancer 36, 1312-1315.
6. Brown, D.A., London, F., 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136.
7. Bruce-Keller, A.J., Umberger, G., McFall, R., Mattson, M.P., 1999. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45, 8-15.
8. Bruno, A.P., Laurent, G., Averbeck, D., Demur, C., Bonnet, J., Bettaieb, A., Levade, T., Jaffrezou, J.P., 1998. Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ. 5, 172-182.
9. Cha, M.C., Jones, P.J., 2000. Energy restriction dilutes the changes related to dietary fat type in membrane phospholipid fatty acid composition in rats. Metabolism 49, 977-983.
10. Chatterjee, S., 1998. Sphingolipids in atherosclerosis and vascular biology. Arterioscler. Thromb. Vase. Biol. 18, 1523-1533.
11. Chmura, S.J., Mauceri, HJ., Advani, S., Heimann, R., Beckett, M.A., Nodzenski, E., Quintans, J., Kufe, D.W., Weichselbaum, R.R., 1997. Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res. 57, 4340-4347.
12. Dbaibo, G.S., Perry, D.K., Gamard, C.J., Platt, R., Poirier, G.G., Obeid, L.M., Hannun, Y.A., 1997. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185, 481-490.
13. Dbaibo, G.S., Pushkareva, M.Y., Rachid, R.A., Alter, N., Smyth, M.J., Obeid, L.M., Hannun, Y.A., 1998. p53-dependent ceramide response to genotoxic stress. J. Clin. Invest. 102, 329-339.
14. Dobrowslry, R.T., Kamibayashi, C., Mumby, M.C., Hannun, Y.A., 1993. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268, 15523-15530.
15. Duan, W., Mattson, M.P., 1999. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57, 195-206.
16. Dutton, M.F., 1996. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol. Ther. 70, 137-161.
17. Farooqui, A.A., Yang, H.C., Rosenberger, T.A., Horrocks, L.A., 1997. Phospholipase A2 and its role in brain tissue. J. Neurochem. 69, 889-901.
18. Farrell, A.M., et al., 1998. UVB irradiation up-regulates serine palmitoyltransferase in cultured human keratinocytes. J. Lipid Res. 39, 2031-2038.
19. France-Lanord, V., Brugg, B., Michel, P.P., Agid, Y., Ruberg, M., 1997. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J. Neurochem. 69, 1612-1621.
20. Garcia-Ruiz, C., Colell, A., Mari, M., Morales, A., Fernandez-Checa, J.C., 1997. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 272, 11369-11377.
21. Geley, S., Hartmann, B.L., Kofler, R., 1997. Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA. FEES Lett. 400, 15-18.
22. Giusto, N.M., et al., 1992. Effects of aging on the conent, composition and synthesis of sphingomyelin in the central nervous system. Lipids 27, 835-839.
23. Goodman, Y., Mattson, M.P., 1996. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J. Neurochem. 6, 869-872.
24. Gormley, G.J., 1995. Finasteride: a clinical review. Biomed. Pharmacother. 49, 319-324.
25. Gudz, T.I., et al., 1997. Direct inhibition of mitochondrial respiratory chain complex II by cell-permiable ceramide. J. Biol. Chem. 272, 24154-24158.
26. Guo, Z., Ersoz, A., Butterfield, D.A., Mattson, M.P., 2000. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose transport and mitochondrial function after exposure to amyloid -peptide and oxidative and metabolic insults. J. Neurochem. 75, 314-320.
27. Hannun, Y.A., Obeid, L.M., 1997. Ceramide and the eukaryotic stress response. Biochem. Soc. Trans. 25, 1171-1175.
28. Hartfield, P.J., Mayne, G.C., Murray, A.W., 1997. Ceramide induces apoptosis in PC 12 cells. FEBS Lett. 401, 148-152.
29. Horinouchi, K., Erlich, S., Perl, D.P., Ferlinz, K., Bisgaier, C.L., Sandhoff, K., Desnick, R.J., Stewart, C.L., Schuchman, E.H., 1995. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Gen. 10, 288-293.
30. Irie, F., Hirabayashi, Y., 1998. Application of exogenous ceramide to cultured rat spinal motoneurons promotes survival or death by regulation of apoptosis depending on its concentrations. J. Neurosci. Res. 54, 475-485.
31. Jarvis, W.D., Kolesnick, R.N., Fornari, F.A., Traylor, R.S., Gewirtz, D.A., Grant, S., 1994. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91, 73-77.
32. Jayadev, S., Linardic, C.M., Hannun, T.A., 1994. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor. J. Biol. Chem. 269, 5757-5763.
33. Jayadev, S., Hayter, H.L., Andrieu, N., Gamard, C.J., Liu, B., Balu, R., Hayakawa, M., Ito, F., Hannun, Y.A., 1997. Phospholipase A2 is necessary for tumor necrosis factor induced ceramide generation in L929 cells. J. Biol. Chem. 272, 17 196-17203.
34. Jones, M.J., Murray, A.W., 1995. Evidence that ceramide selectively inhibits protein kinase C-a translocation and modulates bradykinin activation of phospholipase D. J. Bio. Chem. 270, 5007-5013.
35. Jung, E.M., Griner, R.D., Mann-Blakeney, R., Bollag, W.B., 1998. A potential role for ceramide in the regulation of mouse epidermal keratinocyte proliferation and differentiation. J. Invest. Dermatol. 110, 318-323.
36. Kolodny, E.H., 2000. Niemann-Pick disease. Curr. Opin. Hematol. 7, 48-52.
37. Kreder, D., Adam-Klages, S., Wiegmann, K., Scherer, G., Plitz, T., Jensen, J.M., Proksch, E., Steinmann, J., Pfeffer, K., Kronke, M., 1998. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J. 18, 2472-2479.
38. Lee, J., Duan, W., Long, J.M., Ingram, D.K., Mattson, M.P., 2000. Dietary restriction increases survival of newly-generated neural cells and induces BDNF expression in the dentate gyrus of rats. J. Mol. Neurosci. 15, 99-108.
39. Levine, J.W., Thompson, T.E., Barenholz, Y., Huang, C., 1985. Two types of hydrocarbon chain interdigitation in sphinomyelin bilayers. Biochemistry 24, 6282-6286.
40. Lightle, S.A., et al., 2000. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech. Ageing Dev. 120, 111-125.
41. Liu, B., Hannun, Y.A., 1997. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem. 272, 16281-16287.
42. Liu, J., Mathias, S., Yang, Z., Kolesnick, R.N. 1994, Renaturation and tumor necrosis factor - a stimulation of a 97-kDa ceramide-activated protein kinase, J. Biol. Chem. 269, 3047-3052.
43. Longo, C.A., et al., 1997. Sphingomyelin metabolism is developmentally regulated in rat lung. Am. J. Respir. Cell Mol. Biol. 16, 605-612.
44. Lopez-Marure, R., Ventura, J.L., Sanchez, L., Montano, L.F., Zentella, A., 2000. Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels. Eur. J. Biochem. 267, 4325-4333.
45. Mansat-de Mas, V., Bezombes, C., Quillet-Mary, A., Bettaleb, A., D'orgeix, A.D., Laurent, G., Jaffrezou, J.P., 1999. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol. Pharmacol. 56, 867-874.
46. Mathias, S., Pena, L.A., Kolesnick, R.N., 1998. Signal transduction of stress via ceramide. Biochem. J. 335, 465-480.
47. Mattson, M.P., Goodman, Y., Luo, H., Fu, W., Furukawa, K., 1997. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese Superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
48. Mattson, M.P., 2000a. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129.
49. Mattson, M.P., 2000b. Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res. 886, 47-53.
50. Mattson, M.P., Camandola, S., 2001. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247-254.
51. Mattson, M.P., Klapper, W., 2001. Emerging roles for telomerase in neuronal development and apoptosis. J. Neurosci. Res. 63, 1-9.
52. Merrill, A.H., Schmelz, E.M., Wang, E., Schroeder, J.J., Dillehay, D.L., Riley, R.T., 1995. Role of dietary sphingolipids and inhibitors of sphingolipid metabolism in cancer and other diseases. J. Nutr. 125, S1677-S1682.
53. Merrill, A.H., Schmelz, E.M., Wang, E., Dillehay, D.L., Rice, L.G., Meredith, F., Riley, R.T., 1997. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. J. Nutr. 127, S830-S833.
54. Mitoma, J., et al., 1998. Bipotential roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners. J. Neurosci. Res. 51, 712-722.
55. Pillai, S., Mahajan, M., Carlomusto, M., 1999. Ceramide potentiates, but sphingomyelin inhibits, vitamin D-induced keratinocyte differentiation: comparison between keratinocytes and HL-60 cells. Arch. Dermatol. Res. 291, 284-289.
56. Pruschy, M., Resch, H., Shi, Y.Q., Aalame, N., Glanzmann, C., Bodis, S., 1999. Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells. Br. J. Cancer 80, 693-698.
57. Rebecchi, M.J., Pentyala, S.N., 2000. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80, 1291-1335.
58. Rink, L., Cakman, L, Kirchner, H., 1998. Altered cytokine production in the elderly. Mech. Ageing Dev. 102, 199-209.
59. Rotta, L.N., et al. 1999, Under-nutrition decreases serine palmitoyltransferase activity in developing rat hypothalamus, Ann. Nutr. Metab. 43, 152-158.
60. Russo, I.H., Russo, J., 1998. Role of hormones in mammary cancer initiation and progression. J. Mammary Gland Biol. Neoplasia. 3, 49-61.
61. Ruvolo, P.P., et al., 1999. Ceramide induces Bcl-2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274, 20296-20300.
62. Santana, P., Pena, L.A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E.H., Fuks, Z., Kolesnick, R., 1996. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189-199.
63. Sawai, H., Okazaki, T., Yamamoto, H., Okano, H., Takeda, Y., Tashima, M., Sawada, H., Okuma, M., Ishikura, H., Umehara, H., Domae, N., 1995. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270, 27326-27331.
64. Schütze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., Kronke, M., 1992. TNF activates NF-KB by phosphatidylcholine-specific phospholipase C-induced acidic sphingomyelin breakdown. Cell 71, 765-776.
65. Schutze, S., Machleidt, T., Adam, D., Schwandner, R., Wiegmann, K., Kruse, M.L., Heinrich, M., Wickel, M., Kronke, M., 1999. Inhibition of receptor internalization by monodansyl cadaverine selectively blocks p55 TNF receptor death domain signaling. J. Biol Chem. 274, 10203-10212.
66. Schwandner, R., Wiegmann, K., Bernardo, K., Kreder, D., Kronke, M., 1998. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273, 5916-5922.
67. Sheikh, M.S., Fornace, A.J. Jr., 2000. Role of p53 family members in apoptosis. J. Cell Physiol. 182, 171-181.
68. Smyth, M.J., Perry, D.K., Zhang, J., Poirier, G.G., Hannun, Y.A., Obeid, L.M., 1996. prICE: a downstream target for ceramide induced apoptosis and for the inhibitory action of Bcl-2. Biochem. J. 316, 25-28.
69. Tacconi, M.T., Lugona, L., Salmona, M., Pitsikas, N., Algeri, S., 1991. Aging and food restriction: effect on lipids of cerebral cortex. Neurobiol. Aging 12, 55-59.
70. Venkataraman, K., Futerman, A.H., 2000. Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol. 10, 408-412.
71. Wallach, D., 1997. Cell death induction by TNF: a matter of self control. TIBS 22, 107-109.
72. Wang, Y.M., Seibenhener, M.L., Vandenplas, M.L., Woolen, M.W., 1999a. A typical PKC zeta is activated by ceramide, resulting in coactivation of NF-KB/JNK kinase and cell survival. J. Neurosci. Res. 55, 293-302.
73. Wang, X.Z., Beebe, J.R., Pwiti, L., Bielawska, A., Smyth, M.J., 1999b. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res. 59, 5842-5848.
74. Weindruch, R., Sohal, R.S., 1997. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. New Eng. J. Med. 337, 986-994.
75. Westwick, J.K., Bielawska, A.E., Dbaibo, G., Hannun, Y.A., Brenner, D.A., 1995. Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270, 22689-22692.
76. Yu, Z.F., Mattson, M.P., 1999. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57, 830-839.
77. Yu, Z., Nikolova-Karakashian, M., Zhou, D., Cheng, G., Schuchman, E.H., Mattson, M.P., 2000. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J. Mol. Neurosci. 15, 85-98.
78. Zhang, Y., Yan, B., Delikat, S., Bayoumy, S., Lin, X.H., Basu, S., MeGinley, M., Chn-Hui, P.Y., Ichenstein, H., Kolesnick, R., 1997. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63-72.
79. Zhu, H., Guo, Q., Mattson, M.P., 1999. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 842, 224-229.